NO983990D0 - Aminotetralin-derivater og blandinger og metode for anvendelse derav - Google Patents

Aminotetralin-derivater og blandinger og metode for anvendelse derav

Info

Publication number: NO983990D0
Authority: NO; Norway
Prior art keywords: hydrogen; mixtures; aminotetralin derivatives; alkoxy; halogen
Prior art date: 1996-03-01

Application number

NO983990A

Other languages

English (en)

Norwegian (no)

Other versions

NO983990L (no

Inventor

Edward John Warawa

Bernard Migler

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-01

Filing date

1998-08-31

Publication date

1998-08-31

1998-08-31 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

1998-08-31 Publication of NO983990D0 publication Critical patent/NO983990D0/no

1998-08-31 Publication of NO983990L publication Critical patent/NO983990L/no

Links

JRZGPXSSNPTNMA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-amine Chemical class C1=CC=C2C(N)CCCC2=C1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
150000002431 hydrogen Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical group 0.000 abstract 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
208000016285 Movement disease Diseases 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

NO983990A 1996-03-01 1998-08-31 Aminotetralin-derivater og blandinger og metode for anvendelse derav NO983990L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1264096P	1996-03-01	1996-03-01
PCT/GB1997/000516 WO1997031887A1 (en)	1996-03-01	1997-02-25	Aminotetralin derivatives and compositions and method of use thereof

Publications (2)

Publication Number	Publication Date
NO983990D0 true NO983990D0 (no)	1998-08-31
NO983990L NO983990L (no)	1998-08-31

Family

ID=21755962

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983990A NO983990L (no)	1996-03-01	1998-08-31	Aminotetralin-derivater og blandinger og metode for anvendelse derav

Country Status (14)

Country	Link
US (1)	US5807897A (de)
EP (1)	EP0883599B1 (de)
JP (1)	JP4083221B2 (de)
KR (1)	KR19990087369A (de)
CN (1)	CN1212682A (de)
AT (1)	ATE218535T1 (de)
AU (1)	AU733264B2 (de)
DE (1)	DE69713067T2 (de)
IL (1)	IL125907A0 (de)
NO (1)	NO983990L (de)
NZ (1)	NZ330974A (de)
TW (1)	TW409113B (de)
WO (1)	WO1997031887A1 (de)
ZA (1)	ZA971670B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9726736D0 (en)	1997-12-18	1998-02-18	Zeneca Ltd	Chemical compounds
GB9914015D0 (en) *	1999-06-17	1999-08-18	Zeneca Ltd	Chemical compounds
AU1874500A (en) *	1998-12-24	2000-07-31	Astrazeneca Ab	1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
GB9914025D0 (en) *	1999-06-17	1999-08-18	Zeneca Ltd	Chemical compounds
GB9914024D0 (en) *	1999-06-17	1999-08-18	Zeneca Ltd	Chemical compounds
BRPI0413595B8 (pt) *	2003-08-18	2021-05-25	H Lundbeck As	sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto
TWI376373B (en) *	2005-02-16	2012-11-11	Lundbeck & Co As H	Crystalline base of a pharmaceutical compound
TWI453198B (zh) *	2005-02-16	2014-09-21	Lundbeck & Co As H	製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
EA018927B1 (ru) *	2008-05-07	2013-11-29	Х. Лундбекк А/С	Способ лечения когнитивного расстройства, ассоциированного с шизофренией
AU2009298264A1 (en) *	2008-10-03	2010-04-08	H. Lundbeck A/S	Oral formulation
BR112023025599A2 (pt)	2021-06-08	2024-02-20	Entheogenix Biosciences Inc	Ativadores de dimetoxifenilalquilamina de receptores de serotonina.
EP4457203A4 (de) *	2021-12-27	2025-12-17	Atai Therapeutics Inc	Aminotetralin-aktivatoren von serotoninrezeptoren
EP4704822A1 (de)	2023-05-01	2026-03-11	ATAI Therapeutics, Inc.	Zusammensetzungen und verfahren zur behandlung von erkrankungen und störungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4320148A (en) *	1980-11-24	1982-03-16	Smithkline Corporation	2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US5225596A (en) *	1989-01-09	1993-07-06	The Upjohn Company	Halo substituted aminotetralins
SE8904127D0 (sv) *	1989-12-07	1989-12-07	Astra Ab	New biocyclic amino-substituted compounds
EP0450238A1 (de) *	1990-03-30	1991-10-09	Merrell Dow Pharmaceuticals Inc.	Verbindungen für die Behandlung von Migräne

1997
- 1997-02-21 US US08/804,195 patent/US5807897A/en not_active Expired - Lifetime
- 1997-02-25 WO PCT/GB1997/000516 patent/WO1997031887A1/en not_active Ceased
- 1997-02-25 EP EP97905261A patent/EP0883599B1/de not_active Expired - Lifetime
- 1997-02-25 CN CN97192657A patent/CN1212682A/zh active Pending
- 1997-02-25 AU AU18879/97A patent/AU733264B2/en not_active Ceased
- 1997-02-25 KR KR1019980706779A patent/KR19990087369A/ko not_active Withdrawn
- 1997-02-25 JP JP53069697A patent/JP4083221B2/ja not_active Expired - Fee Related
- 1997-02-25 AT AT97905261T patent/ATE218535T1/de not_active IP Right Cessation
- 1997-02-25 IL IL12590797A patent/IL125907A0/xx unknown
- 1997-02-25 NZ NZ330974A patent/NZ330974A/xx unknown
- 1997-02-25 DE DE69713067T patent/DE69713067T2/de not_active Expired - Lifetime
- 1997-02-26 ZA ZA9701670A patent/ZA971670B/xx unknown
- 1997-02-26 TW TW086102356A patent/TW409113B/zh not_active IP Right Cessation
1998
- 1998-08-31 NO NO983990A patent/NO983990L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0883599A1 (de)	1998-12-16
US5807897A (en)	1998-09-15
NZ330974A (en)	2000-05-26
EP0883599B1 (de)	2002-06-05
ZA971670B (en)	1997-09-01
NO983990L (no)	1998-08-31
IL125907A0 (en)	1999-04-11
ATE218535T1 (de)	2002-06-15
DE69713067T2 (de)	2002-12-19
WO1997031887A1 (en)	1997-09-04
JP4083221B2 (ja)	2008-04-30
TW409113B (en)	2000-10-21
JP2000506137A (ja)	2000-05-23
CN1212682A (zh)	1999-03-31
DE69713067D1 (de)	2002-07-11
KR19990087369A (ko)	1999-12-27
AU733264B2 (en)	2001-05-10
AU1887997A (en)	1997-09-16

Similar Documents

Publication	Publication Date	Title
CA2387517A1 (en)	2001-04-19	Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
GB0005251D0 (en)	2000-04-26	Therapeutic compounds
AP9701019A0 (en)	1997-07-31	Phenylamino-substituted tricycle derivatives.
LU91751I2 (fr)	2011-01-04	Asenapin et ses dérivés pharmaceutiquement acceptables (SYCREST®)
ES2160949T3 (es)	2001-11-16	Derivados de fenilen-sulfonamida sustituidos en meta.
NO983990D0 (no)	1998-08-31	Aminotetralin-derivater og blandinger og metode for anvendelse derav
YU191491A (sh)	1994-04-05	Nova so 3- 2-(dimetilamino)etil -n-metil-14-indol-5-metansulfonamida
IL142768A0 (en)	2002-03-10	N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DK0583485T3 (da)	1997-10-06	Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
NO20030724D0 (no)	2003-02-14	Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
NO985979D0 (no)	1998-12-18	1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse
DK0572635T3 (da)	1997-06-16	Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
MX9708595A (es)	1998-02-28	Derivados de bencil piperidina como agentes farmaceuticos.
IL108969A0 (en)	1994-06-24	Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
LV11728A (lv)	1997-04-20	Farmaceitiska kompozicija
GB9108629D0 (en)	1991-06-12	Heterocyclic pharmaceutical compounds,preparation and use
CA2136008A1 (en)	1994-10-13	Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation
TW349864B (en)	1999-01-11	Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
AP9801235A0 (en)	1999-11-07	Erythromycin derivatives.
AP2002002595A0 (en)	2002-09-30	Heterocyclic amide derivatives.
AP9901559A0 (en)	1999-06-30	Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
DK0401093T3 (da)	1995-07-10	Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse
UA34451C2 (uk)	2001-03-15	2,3,4,5-тетрагідро-1н-3-бензазепіни, що використовуються для лікування захворювань центральної нервової системи, спосіб їх одержання, фармацевтична композиція та спосіб лікування захворювань центральної нервової системи
PT1082116E (pt)	2003-08-29	Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
GR3020922T3 (en)	1996-12-31	Amide derivatives of 1-amino-octahydropyrido[2,1-c][1,4]oxazine, processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2002-04-08	FC2A	Withdrawal, rejection or dismissal of laid open patent application